PRO-DEX, INC. Announces Fiscal 2009 Fourth Quarter and Full-ye...(------ ------- Cash and Cas...),Health
Navigation Links
PRO-DEX, INC. Announces Fiscal 2009 Fourth Quarter and Full-year Results
Date:9/17/2009
------ ------- Cash and Cash Equivalents, end of year $1,124,000 $517,000 ========== ======== Supplemental Information Cash paid for interest $230,000 $181,000 Cash paid for income taxes $ - $560,000 --- --------
'/>"/>
| SOURCE Pro-Dex, Inc. Copyright©2009 PR Newswire. All rights reserved |
Related medicine news :
1. Pro-Dex, Inc. Announces Fiscal 2009 Fourth Quarter Financial Results Conference Call and Webcast
2. Pro-Dex, Inc. Announces Fiscal 2009 Third Quarter Financial Results Conference Call and Webcast
3. Pro-Dex, Inc. Announces Fiscal 2008 Third Quarter Financial Results Conference Call and Webcast
4. Pro-Dex, Inc. Provides Updates on Key Developments
5. American Pacific Announces Executive Change
6. United Way of Greater Los Angeles Announces Matching Fund Launched by Two Local Philanthropists
7. Satellite Healthcare Announces the Recipients of the 2009 Norman S. Coplon Extramural Grants
8. AAF(R) Announces MEGAcel(TM) I Filter with Helior(TM) Media
9. SEQUENOM Announces Launch of SensiGene Cystic Fibrosis Carrier Screening Test
10. Neogen Corporation Announces 1st Quarter Results Conference Call
11. MDS Announces CEO Transition Plan
Post Your Comments:
Breaking Medicine News(10 mins):Health News:Docs Not Giving Clear Advice on Infant Sleep Positions 2Health News:Docs Not Giving Clear Advice on Infant Sleep Positions 3Health News:Health Reform is About You and Me, Not One or the Other 2Health News:Health Reform is About You and Me, Not One or the Other 3Health News:West Nile virus infection may persist in kidneys years after initial infection 2Health News:West Nile virus infection may persist in kidneys years after initial infection 3Health News:Independence Blue Cross Supports Pennsylvania Fitness Program with Grants to 10 Area Schools 2Health News:Independence Blue Cross Supports Pennsylvania Fitness Program with Grants to 10 Area Schools 3Health News:Lung Cancer Alliance-Georgia Hails Senate Leadership on Lung Cancer Mortality Reduction Act of 2009 2Health News:Lung Cancer Alliance-Georgia Hails Senate Leadership on Lung Cancer Mortality Reduction Act of 2009 3
[0] Docs Not Giving Clear Advice on Infant Sleep Positions[0] Health Reform is About You and Me, Not One or the Other[0] West Nile virus infection may persist in kidneys years after initial infection[0] Independence Blue Cross Supports Pennsylvania Fitness Program with Grants to 10 Area Schools[0] Lung Cancer Alliance-Georgia Hails Senate Leadership on Lung Cancer Mortality Reduction Act of 2009
Other Medicine News:Health News:Key Blood Test Protein May Not Cause Heart Disease 2Health News:Key Blood Test Protein May Not Cause Heart Disease 3Health News:eMatchPhysicians.com Launches to Provide Physicians and Hiring Organizations with a Better Way to Find the Perfect Physician Job 2Health News:eMatchPhysicians.com Launches to Provide Physicians and Hiring Organizations with a Better Way to Find the Perfect Physician Job 3Health News:Regence Teams With U.S. Bank to Offer New Health Savings Account Solution 2Health News:MU study identifies patient strategies for managing symptoms of lymphedema 2Health News:MU study identifies patient strategies for managing symptoms of lymphedema 3Health News:Women at Higher Risk for Pulmonary Hypertension 2Health News:Health-care barriers for undocumented immigrants: Raising tuberculosis risk? 2
Key Blood Test Protein May Not Cause Heart DiseaseeMatchPhysicians.com Launches to Provide Physicians and Hiring Organizations with a Better Way to Find the Perfect Physician Job Regence Teams With U.S. Bank to Offer New Health Savings Account SolutionMU study identifies patient strategies for managing symptoms of lymphedemaWomen at Higher Risk for Pulmonary HypertensionHealth-care barriers for undocumented immigrants: Raising tuberculosis risk?
Breaking Medicine Technology:Amgen Board Authorizes $5 Billion Increase in Stock Repurchase Program 2Amgen Board Authorizes $5 Billion Increase in Stock Repurchase Program 3New Research Shows a Vitamin/Nutriceutical Formulation Improves Memory and Cognitive Performance in Community-Dwelling Adults 2TaiGen Biotechnology Reports Phase I and Preclinical Data for TG-0054 at the 2009 American Society of Hematology (ASH) Annual Meeting 2For Patients With Irritable Bowel Syndrome 28IBS 29 iPhone to the Rescue 47442 1For Patients With Irritable Bowel Syndrome 28IBS 29 iPhone to the Rescue 47442 2For Patients With Irritable Bowel Syndrome 28IBS 29 iPhone to the Rescue 47442 3Ascenta Therapeutics Announces Presentation of Promising Results From Clinical Trials of AT 101 in Prostate Brain and Lung Cancers at 2009 ASCO Annu 12378 1Ascenta Therapeutics Announces Presentation of Promising Results From Clinical Trials of AT 101 in Prostate Brain and Lung Cancers at 2009 ASCO Annu 12378 2Ascenta Therapeutics Announces Presentation of Promising Results From Clinical Trials of AT 101 in Prostate Brain and Lung Cancers at 2009 ASCO Annu 12378 3Ascenta Therapeutics Announces Presentation of Promising Results From Clinical Trials of AT 101 in Prostate Brain and Lung Cancers at 2009 ASCO Annu 12378 4Ascenta Therapeutics Announces Presentation of Promising Results From Clinical Trials of AT 101 in Prostate Brain and Lung Cancers at 2009 ASCO Annu 12378 5Study shows gay couples want legal rights regardless of marriage 47439 1Study shows gay couples want legal rights regardless of marriage 47439 2
[0] Amgen Board Authorizes $5 Billion Increase in Stock Repurchase Program[0] New Research Shows a Vitamin/Nutriceutical Formulation Improves Memory and Cognitive Performance in Community-Dwelling Adults[0] TaiGen Biotechnology Reports Phase I and Preclinical Data for TG-0054 at the 2009 American Society of Hematology (ASH) Annual Meeting
Other Medicine Technology:Scientists at The Karmanos Cancer Institute in Detroit Identify Potential New Target for Breast Cancer Therapy 2Scientists at The Karmanos Cancer Institute in Detroit Identify Potential New Target for Breast Cancer Therapy 3New Preliminary Data from Two Studies Show Clinical Activity of Neratinib in Combination with Trastuzumab and in Combination with Paclitaxel in Advanced HER-2 Positive Breast Cancer 2New Preliminary Data from Two Studies Show Clinical Activity of Neratinib in Combination with Trastuzumab and in Combination with Paclitaxel in Advanced HER-2 Positive Breast Cancer 3New Preliminary Data from Two Studies Show Clinical Activity of Neratinib in Combination with Trastuzumab and in Combination with Paclitaxel in Advanced HER-2 Positive Breast Cancer 4New Preliminary Data from Two Studies Show Clinical Activity of Neratinib in Combination with Trastuzumab and in Combination with Paclitaxel in Advanced HER-2 Positive Breast Cancer 5
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |